Genomics

Dataset Information

0

Ena-DATASET-SC-15-06-2016-10:23:08:608-358 - samples


ABSTRACT: Description not provided

PROVIDER: EGAD00001002191 | EGA |

REPOSITORIES: EGA

altmetric image

Publications


The development of targeted inhibitors, like vemurafenib, has greatly improved the clinical outcome of BRAF(V600E) metastatic melanoma. However, resistance to such compounds represents a formidable problem. Using whole-exome sequencing and functional analyses, we have investigated the nature and pleiotropy of vemurafenib resistance in a melanoma patient carrying multiple drug-resistant metastases. Resistance was caused by a plethora of mechanisms, all of which reactivated the MAPK pathway. In ad  ...[more]

Similar Datasets

| EGAD00001003387 | EGA
| EGAD00001002278 | EGA
| EGAD00001001927 | EGA
| S-IHECRE00000142.1 | biostudies-other
| EGAD00001008198 | EGA
| EGAD00001001036 | EGA
| S-IHECRE00000061.1 | biostudies-other
| S-IHECRE00000041.1 | biostudies-other
| S-IHECRE00000129.1 | biostudies-other
| S-IHECRE00000097.1 | biostudies-other